Biocon
Healthcare
Biocon-backed Bicara Therapeutics raises $315 mn in US IPO
Bicara Therapeutics raised $315 million in its initial public offering in the United States, the TPG-backed cancer therapy developer said ......
Healthcare
Exclusive: Biocon weighs fresh funding for PE-backed biosimilars unit
Biocon Ltd is looking to raise fresh funding for its biosimilars unit that has previously secured capital from five private ......
General
Grapevine: Actis may trim Profectus stake; Goldman to double down on MoEngage
Private equity firm Actis is looking to sell a stake in Profectus Capital, a non-banking finance company that it fully ......
Healthcare
Syngene rakes in $131 mn from Singapore's GIC
Singapore’s sovereign wealth fund GIC on Wednesday invested Rs 1,075.2 crore (around $131 million) in drug research company Syngene International ......
Healthcare
Biocon Biologics appoints new MD, CEO
Biocon Biologics on Monday said it has appointed Shreehas Tambe as managing director and chief executive officer of the company. ......
Finance
Deals Digest: PE, VC deals value remains little changed this week
Investments by venture capital (VC) and private equity (PE) dipped 5.9% this week to $287 million from last week’s $305 ......
Healthcare
Biocon concludes Viatris' $3 bn acquisition
Biosimilars manufacturing arm of Biocon Ltd, Biocon Biologics, on Tuesday announced completion of acquisition of Viatris' global biosimilars business for ......
Healthcare
Kiran Mazumdar-Shaw co-founded biotech startup raises Series A funding
Immuneel Therapeutics Pvt Ltd, co-founded by Biocon founder Kiran Mazumdar-Shaw, has raised around $15 million (Rs 116 crore) in a ......
Healthcare
India's Biocon in talks with Mylan to merge biosimilar businesses - Moneycontrol
Indian drugmaker Biocon Ltd is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news ......
Healthcare
Indian pharma firms go local seeking to end reliance on China
Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients (API) or trying to make them in-house ......